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A B S T R A C T   
Ag/Ga were incorporated into resorbable orthopaedic phosphate bioactive glasses (PBG, containing P, Ca, Mg, 
Na, and Fe) thin films to demonstrate their potential to limit growth of Staphylococcus aureus and Escherichia coli 
in post-operative prosthetic implantation. Dual target consecutive co-sputtering was uniquely employed to 
produce a 46 nm Ag:PBG composite observed by high resolution TEM to consist of uniformly dispersed ~5 nm 
metallic Ag nano-particles in a glass matrix. Ga3+ was integrated into a phosphate glass preform target which was 
magnetron sputtered to film thicknesses of ~400 or 1400 nm. All coatings exhibited high surface energy of 
75.4–77.3 mN/m, attributed to the presence of hydrolytic P–O–P structural surface bonds. Degradation profiles 
obtained in deionized water, nutrient broth and cell culture medium showed varying ion release profiles, 
whereby Ga release was measured in 1400 nm coating by ICP-MS to be ~6, 27, and 4 ppm respectively, fully 
dissolving by 24 h. Solubility of Ag nanoparticles was only observed in nutrient broth (~9 ppm by 24 h). 
Quantification of colony forming units after 24 h showed encouraging antibacterial efficacy towards both 
S. aureus (4-log reduction for Ag:PBG and 6-log reduction for Ga-PBG≈1400 nm) and E. coli (5-log reduction for 
all physical vapour deposited layers) strains. Human Hs27 fibroblast and mesenchymal stem cell line in vitro tests 
indicated good cytocompatibility for all sputtered layers, with a marginal cell proliferation inertia in the case of 
the Ag:PBG composite thin film. The study therefore highlights the (i) significant manufacturing development via 
the controlled inclusion of metallic nanoparticles into a PBG glass matrix by dual consecutive target co-sputtering 
and (ii) potential of PBG resorbable thin-film structures to incorporate and release cytocompatible/antibacterial 
oxides. Both architectures showed prospective bio-functional performance for a future generation of endo- 
osseous implant-type coatings.   
1. Introduction 
The efficacy of conventional antibiotic treatments as a prophylactic 
measure for preventing post-surgery infection, in both the cases of 
metallic implant joint endoprostheses and dental fixtures (vastly based 
on titanium and titanium super-alloys, collectively accepted as gold 
standards), is declining due to the rise of resistant bacterial strains [1–3]. 
For instance, the UK National Joint Registry reported in 2020 that in-
fections led to surgeries in 14.8% of primary hip replacement implants 
that had an associated first revision [4]. Antibiotic loaded poly(methyl 
methacrylate) cements used to fix in place the titanium-based joint 
implants are no longer practical for the next generation of medical de-
vices, which have advanced towards cementless, bioactive devices, 
intended to prolong implant fixation and minimise the foreign body 
response. Antimicrobial traits are similarly of high importance for dental 
implants, since the complete sterility of the oral environment cannot be 
achieved. 
The application of thin films and thick coatings of bioceramic- and/ 
Peer review under responsibility of KeAi Communications Co., Ltd. 
* Corresponding author. 
E-mail addresses: bryan.stuart19@gmail.com (B.W. Stuart), david.grant@nottingham.ac.uk (D.M. Grant).  
Contents lists available at ScienceDirect 
Bioactive Materials 
journal homepage: www.sciencedirect.com/journal/bioactive-materials 
https://doi.org/10.1016/j.bioactmat.2021.05.055 
Received 13 March 2021; Received in revised form 29 May 2021; Accepted 29 May 2021   
Bioactive Materials xxx (xxxx) xxx
2
or bioglass-based materials on the surface of endo-osseous metallic im-
plants, containing various antimicrobial agents, has recently emerged as 
a potent solution for this ever-growing healthcare system demand [5,6]. 
The most explored materials in this respect are either the phosphate- 
based (i.e., calcium phosphates [7,8], phosphate glasses [9]) or 
phosphate-containing (silica glasses [10,11]), all having the advantage 
of absent or limited cytotoxic effects [7–11]. Plasma sprayed pure hy-
droxyapatite [HA, Ca10(PO4)(OH)2] coatings have been clinically used 
since the 1980’s, however, problems of poor biomimicry and mechani-
cal spallation have been associated with varying crystallinity and 
inherent minimum coating thicknesses in the tens to hundreds of mi-
crons [12]. Novel technologies based on thin bioactive films, capable of 
combatting infection through the release of osteogenic and antimicro-
bial metals, are currently under investigation worldwide [13–17], 
relying on alternative deposition techniques, with the most prominent 
[18] being electrophoretic/electrochemical deposition [19], sol-gel 
[20], sputtering [21] and pulsed laser deposition [22]. 
Phosphate bioactive glass (PBG) thin films may function as thera-
peutic carriers by incorporating and subsequently releasing osteogenic 
elements such as Ca, P, and Mg to stimulate bone regeneration and 
enhance the fixation between the host tissue and the PBG coated implant 
[23–27]. The supplemental incorporation of antimicrobial agents could 
expand their biofunctionality. In this respect, in the framework of this 
study two effective antimicrobial elements [18,28] were selected: Silver 
(Ag) and Gallium (Ga). 
The antimicrobial ability of Ag has been known since antiquity [29]. 
Ag is assumed to inhibit bacterial attachment during and post-surgery 
[28,30]. Only recently has its function been pinpointed to its release 
in form of ions from the erosion of nano-particulates in solution [30], 
opening the path towards a more precise design of implant constructs. 
However, cautionary measures need to be considered when employing 
Ag, since this specific antimicrobial is known to be biologically haz-
ardous when found/released in large amounts [30,31]. Therefore, the 
application of very thin bio-functionalization layers (containing low to 
moderate contents of Ag) on the surface of metallic implants would be 
recommended. 
Gallium [Ga (III)] ions have recently emerged as part of an alternate 
antibacterial strategy, due to their ability to disturb specific cellular 
processes (i.e., metabolism and nutrition of microorganisms), as opposed 
to more conventionally available drugs which instead target biosyn-
thesis of the cell wall or DNA replication [32]. Ga disrupts ferric 
iron-dependent metabolic pathways, and due to the importance of these 
in the bacterial physiology and pathogenicity, it has the potency to 
inhibit microbial growth [33,34]. In particular, bacteria mistake Ga3+
for Fe3+ which leads to cell degradation in response to an inability to 
reduce Ga3+ during redox cycling from Fe3+ to Fe2+. Importantly 
Ga-containing agents have proven effective, in vitro and in vivo, even 
against pan-resistant (multidrug resistant) pathogens [32–36]. In 
particular, Ga has a greater half-maximum cytotoxic concentration with 
respect to Ag [18], therefore it could be used in thicker bioresorbable 
implant-type coatings, which in turn could stimulate the longevity and 
intensity of the antimicrobial-induced effect. 
Ag [37–39] and Ga [40,41] have been incorporated only into bulk 
and powdered PBGs, synthesized by melt-quenching or peroxidation 
methods. No Ag- or Ga-containing PBG coatings with demonstrated 
bio-functionality have been reported to the best of our knowledge. 
Physical vapour deposition (PVD) techniques are attractive due to their 
propensity to generate high quality mechanically adherent and 
conformal thin films [26,42–45], and have been used to deposit PBG 
layers in the P2O5–MgO–CaO–Na2O [46], P2O5–CaO–Na2O–Fe2O3 [47], 
P2O5–MgO–CaO–Na2O–Fe2O3 [14,28,48], and P2O5-ZnO-Nb2O5 [49] 
glass systems. The authors have recently reported on the compositio-
nal/thickness control, mechanical integrity and physical-chemical at-
tributes of PBG coatings modified by Ga-doping and fabricated by 
radio-frequency magnetron sputtering (RF-MS) [50]. 
These scientific and technological state-of-the-art developments 
[7–50] have motivated the search and delineation of new antimicrobial 
implant coating designs, relying on promising methodologies which can 
supersede the longstanding industrial standard of plasma sprayed thick 
coatings. Consequently, in the framework of this study, two independent 
antibacterial strategies based on magnetron sputtered PBG sacrificial 
layers are assessed and promoted for the future prevention of implant 
infections: (1) the dispersion of silver nanoparticles into the glass matrix 
by co-sputtering from two targets resulting in a composite coating; and 
(2) control over the duration of the antimicrobial efficacy by changing 
the thickness of the sacrificial Ga-doped PBG PVD deposited layer. The 
manufacturing routes advanced herein (i.e., thin Ag:PBG composite 
layers or thicker Ga incorporated PBG coatings) aimed to utilise the 
ability of the additional constituting elements (i.e., Ca, Mg, Na, and Fe) 
to tailor the cross-linking of phosphate glass units (as shown in Refs. [48, 
50]) to achieve a suitable degradation timescale capable of facilitating 
the fast release of (i) Ag in its metallic form (known to possess lower 
systemic toxicity with respect to its ionic form [51]) from the composite 
layers or (ii) Ga3+ ions from the glass coatings, within the required 6–24 
h window, and thereby to contribute to the prevention of post-operative 
infections. 
2. Materials and methods 
2.1. Target production 
Two PBG sputtering targets, with a (mol%) composition given in 
Table 1, were produced by melt-quenching (MQ). Briefly, precursors of 
P2O5 (Thermo Fisher Scientific, Waltham, MA, USA; purity >98%), 
MgHPO4⋅3H2O (Sigma Aldrich, St. Louis, MO, USA; purity >97%), 
CaHPO4 (Sigma Aldrich, St. Louis, MO, USA; purity >98%), NaH2PO4 
(Sigma Aldrich, St. Louis, MO, USA; purity >99%), and FePO4⋅2H2O 
(Sigma Aldrich, St. Louis, MO, USA; reagent grade) or Ga2O3 (Sigma 
Aldrich, St. Louis, MO, USA; purity >99.99%) were ad-mixed (in the 
quantities listed in Table 1) and dehydrated at 450 ◦C in a Pt/Rh 90/10% 
crucible for 30 min. Each mixture was melted for 2 h at 1200 ◦C in air. 
The melts were cast at 450 ◦C into graphite moulds, and left to furnace 
cool. The moulds were chosen to produce P57-MQ and Ga-P51-MQ 
sputtering targets of 57 ± 1 and 76 ± 1 mm in diameter, respectively. 
To achieve the desired thicknesses, the base side of each target, to be 
positioned in contact with the magnetron cathode surface, was polished 
down to 6 ± 1 mm using isopropyl alcohol as a lubricant. 
2.2. PBG films deposition by radio-frequency magnetron sputtering 
In this work we aimed to explore the preliminary biological perfor-
mance of two independent coating solutions, based on sacrificial anti-
bacterial layers, for endo-osseous metallic implants. The two approaches 
differ in many respects (e.g., thickness, antibacterial agent nature and 
chemical status), but their goal is the same: obtaining an antibacterial 
effect with reduced interference (if any) on eukaryotic cells. 
A reduced thickness of the Ag:PBG composite sacrificial film was 
chosen to limit the release of silver within the medium and to maintain 
the leached concentrations below the known cytotoxic thresholds pre-
sented within the literature [52,53]. Knowing that the toxicity of Ga is 
far less than that of Ag [18], the manufacture of Ga-doped glass films of 
similar thickness to the Ag:PBG constructs would not be of high interest, 
as the exploration of the full potential of Ga could be missed. Conse-
quently, in this second case, sputtered glass layers with thicknesses of 
one and two orders of magnitude higher were investigated. 
The fabrication of the composite coating consisting of silver nano-
particle embedded PBG (further denoted as Ag:PBG-PVD) was carried 
out with a UDP 650 system (Teer Coatings Ltd., Droitwich, UK) equipped 
with a 13.56 MHz RF power source, using a dual-target consecutive 
magnetron co-sputtering process (see Fig. 1). The chamber was evacu-
ated by consecutive rotary and diffusion pumping stages to a base 
pressure lower than 10− 3 Pa. All depositions were conducted in 0.36 Pa 
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of 99.999% (5 N) Pureshield Argon (gas flow of 125 sccm). The target- 
to-substrate distance was maintained as 40 ± 1 mm. Conditions and 
target potential/temperature were left to equilibrate for 30 min prior to 
commencing deposition by opening of the shutter. In order to incorpo-
rate Ag nanoparticles within the PBG thin film, a second Ag target (57 
mm in diameter) was positioned parallel to the PBG target and separated 
by a distance of 580 mm. RF powers of 100 W and 5 W were set for the 
57 mm diameter PBG and Ag targets, respectively. 
The synthesis method for the production of the Ga-doped PBG films 
(further denoted as Ga-PBG-PVD), was presented in our previous work 
[50]. Here the deposition time was adjusted such as to produce batches 
of Ga-PBG-PVD films of two different thicknesses, i.e., ≈400 and 1400 
nm. For comparison, the main deposition conditions for each type of 
PBG-based layer are summarized in Table 2. 
Certain precautions are required when dealing with soluble/ 
resorbable implant coatings, since (i) the uniform stress distribution at 
the implant/bone interface can be radically and rapidly modified, 
leading to bone loss as a possible long-term result and (ii) in situ implant 
motion could be generated by the formed gap at the interface, leading to 
particulate debris which can cause foreign body chronic inflammatory 
reactions [54]. However, such worries should be significantly reduced 
(if not alleviated) by designs based on lower thickness coatings (with 
respect to the commercial plasma sprayed ones), and thus conformal to 
the topography of the metallic implant surface. On the one hand, the 
overall stiffness and mechanical qualities of the metallic implant would 
be negligibly affected on a large-scale by the application of coatings with 
thicknesses in the range of tens to hundreds of nanometres, and thereby 
these coatings would also negligibly add to any induced stress shielding. 
On the other hand, in the case of the complete dissolution of the thin 
coating layer, the gap between implant and bone would be minimal 
(considering that implants are inserted into threaded holes or in bone 
shafts using low precision tools with positioning errors in the hundreds 
of micrometres), and thus, the in situ movements will be absent. For 
instance, deleterious effects on bone integration were recorded for 
amplitude of motions in the millimetre range [54], which definitely 
could not be the case here. 
Both types of coatings were applied to mirror-polished (i) unalloyed 
commercially pure titanium (cp-Ti discs with diameter of ~10 mm 
diameter, thickness of ~0.82 mm, root square mean roughness of ~6 nm 
determined by as atomic force microscopy for surface areas of 10 × 10 
μm2) and (ii) silicon (Si wafers with size of 24 × 24 mm2, thickness of 
~0.45 mm, root square mean roughness of ~0.1 nm as determined by as 
atomic force microscopy for surface areas of 10 × 10 μm2) substrates 
with a view to undertake (i, ii) physical-chemical analyses and (i) in vitro 
cytocompatibility tests and (ii) antibacterial assays. 
2.3. Physical-chemical characterization 
2.3.1. Fourier transform infra-red (FTIR) spectroscopy 
The structure of the PBG powders (diluted in KBr to a ratio of 1:150) 
and films (deposited by RF-MS on IR transparent Si wafers) was inves-
tigated by FTIR spectroscopy in transmission mode, using a PerkinElmer 
Spectrum BX II spectrometer (PerkinElmer Corporation, Waltham, MA, 
USA). The FTIR spectra were collected in the wave numbers range 
2000–550 cm− 1, at a resolution of 4 cm− 1, and represent the average of 
64 individual scans. 
2.3.2. Transmission electron microscopy (TEM) 
Electron transparent transmission electron microscope (TEM) 
lamellae of Ag:PBG-PVD were prepared using a FEI Quanta 200 3D 
DualBeam FIB-SEM (FEI Company, Hillsboro, OR, USA) and a standard 
focused ion beam (FIB) lift-out method was employed. Representative 
TEM lamellae were taken directly from the as-deposited sample surfaces 
and platinum was deposited directly onto the coating surface in order to 
minimise the surface damage caused by subsequent FIB machining op-
erations during sample preparation. A JEOL 2100F FEG-TEM (JEOL Ltd., 
Tokyo, Japan) operating at 200 kV was employed for conventional 
(parallel beam) bright field transmission electron microscopy (BF-TEM), 
high resolution transmission electron microscopy (HRTEM), bright field 
scanning transmission electron microscopy (BF-STEM), and elemental 
mapping via energy dispersive spectroscopy (EDXS-STEM). EDXS-STEM 
was performed using a 80 mm X-Max EDS detector (Oxford Instruments 
plc, Abingdon, UK). 
Table 1 
Nominal oxide composition (mol%) of the PBG sputtering cathode targets and the quantities of precursors used for their preparation.  
Target code Nominal oxide composition (mol%) 
P2O5 CaO MgO Na2O Fe2O3 Ga2O3 
P57-MQ 57.0 12.0 14.0 14.0 3.0 – 
Ga-P51-MQ 51.5 14.0 18.5 10.0 – 6.0  
Precursor (grams) 
P2O5 CaHPO4 MgHPO4⋅3H2O NaH2PO4 FePO4⋅2H2O Ga2O3 
P57-MQ 38.3 15.5 18.3 29.0 8.4 – 
Ga-P51-MQ 27.4 18.4 24.6 21.1 – 8.6  
Fig. 1. Configuration employed in a TEERUDP-650 sputtering system to 
incorporate silver nano-particles into the PBG glass. The samples were fixed to a 
carrousel and continuously rotated past each cathode and target for consecutive 
deposition of the PBG matrix and silver particles. The process has been labelled 
here as “dual target consecutive magnetron sputtering”. 
Table 2 
RF-MS deposition conditions used for the preparation of the Ag:PBG-PVD and 













Ar 5 N 0.36 100 5 40 
Ga-PBG- 
PVD 
Ar 5 N 1.33 60 – 40  
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2.3.3. Atomic force microscopy (AFM) 
The surface topography of the PBG-based layers was examined by 
AFM, in non-contact mode, by using an NT-MDT NTEGRA Probe 
NanoLaboratory system (NT-MDT Spectrum Instruments, Moscow, 
Russia). A high-resolution silicon NT-MDT NSG01 cantilever was used, 
having a tetrahedral tip, with curvature radius of 6 nm and the cone 
angle at the apex of 7–10◦. The AFM images were scanned over sample 
areas of 10 × 10 and 2 × 2 μm2 and the root mean square roughness 
(RRMS) has been determined. 
2.3.4. Field emission scanning electron microscopy (FE-SEM) 
The surface and cross-sectional morphology of the samples was 
surveyed by FE-SEM in high vacuum, using a Zeiss Gemini 500 (Carl 
Zeiss AG, Oberkochen, Germany), in secondary electron mode, at an 
acceleration voltage of 3 kV. No conductive coating was applied, to 
avoid concealing/obscuring the fine morphological details of the PBG- 
based specimens. 
2.3.5. Energy dispersive X-ray spectroscopy (EDXS) 
The composition of the P57-MQ and Ga-P51-MQ cathode targets and 
Ga-PBG-PVD sputtered films was assessed by EDXS. An INCA EDX 
microanalysis system (Oxford Instruments plc, Abingdon, UK) attached 
to a XL30 scanning electron microscope (Philips N.V., Amsterdam, 
Netherlands) was used. At least four composition analyses have been 
performed on randomly chosen regions of 30 × 30 μm2 of each type of 
the PBG specimens, at an acceleration voltage of 15 kV. 
2.3.6. X-ray photoelectron spectroscopy (XPS) 
X-ray photoelectron spectroscopy (XPS) measurements were per-
formed using a EscaLab Mark II spectrometer (VG Scientific, Waltham, 
MA, USA) with an Al Kα non-monochromatic X-ray source. The spectra 
were acquired at 20 mA and 12 kV emissions. All high resolution spectra 
were charge corrected with respect to adventitious carbon clearly 
defined at 284.8 eV. 
2.3.7. Surface wetting measurements 
The surface wetting properties of the Ag:PBG-PVD and Ga-PBG-PVD 
samples were investigated by static contact angle (CA) measurements, 
using a Drop Shape Analysis system, model DSA 100, from Krüss GmbH 
(Hamburg, Germany). All measurements were performed at room tem-
perature, on at least four independent specimens, by applying the pro-
cedure described in Ref. [55]. Using CA measurements, the solid surface 
free energy (SFE) were calculated. MilliQ water and 1-Bromonaphtalene 
(Sigma Aldrich, St. Louis, MO, USA) were used as standard testing polar 
and dispersive liquids, respectively. The dispersive and polar parts of 
surface tension were obtained by using Owens–Wendt method for two 
test liquids [56]. 
2.4. Preliminary in vitro biological assessments 
2.4.1. Degradation tests and inductively coupled plasma mass spectrometry 
analyses 
Ag:PBG-PVD and Ga-PBG-PVD coated Ti samples were indepen-
dently submerged in 1 mL of media [i.e., deionized (DI) water, Dul-
becco’s Modified Eagle’s Medium (DMEM), and Nutrient Broth (NB) of 
1/3 Meat Bovine, 1/3 Yeast Extract, 1/3 NaCl formulation] in 20 mL 
polypropylene centrifuge tubes. The media was buffered at a pH of 7.4, 
and the assays were performed at a homeostatic temperature of 37 ◦C in 
a 5% CO2 containing incubator. At time points 2, 4, 8, 16 and 24 h, the 
samples were diluted with 9 mL of ultra-pure water. The discs were 
removed and dried under a stream of compressed air. The remaining 10 
mL of media was assessed by inductively coupled plasma mass spec-
trometry (ICP-MS) for degradation products using an iCAP-Q system 
(Thermo Fisher Scientific, Waltham, MA, USA). 
The PBG film mass loss was assessed, prior to and after in vitro 
testing, using a MT5 micro-balance (Mettler Toledo, Columbus, OH, 
USA) with a precision of a 0.001 μg. All experiments were performed in 
quadruplicates. 
2.4.2. Cytocompatibility tests 
The cytocompatibility was assessed in accordance with the ISO 
10993-5:2009 standard [57]. The uncoated (control) and Ag: PBG-PVD, 
Ga-PBG-PVD, PBG coated Ti substrates were dry heat sterilized 
(180 ◦C/1 h). The samples were transferred in a laminar flow hood to 
sterile 24-well plates. 
Human fibroblast cell (Hs27, ATCC® CRL-1634, Manassas, VA, USA) 
and mesenchymal stem cell (hMSC, Lonza, catalogue no. PT-2501, Basel, 
Switzerland) lines were used to test the cytocompatibility of the RF-MS 
PBG-based coatings. The Hs27 cell line was chosen due to the fibro-
blast’s propensity in the human body and due to its implication in many 
tissue healing processes. Fibroblasts are known to possess inter- 
convertibility [58], that allows them to change under adequate stimuli 
into any connective tissue cells, including cells of the bone. The hMSC 
line was selected due to its susceptibility to toxic environments, and its 
importance for longer term health of the tissue. 
2.4.2.1. Cell culturing.  
(a) The Hs27 cells were cultivated with DMEM with L-glutamine, 
supplemented with 10% fetal bovine serum (FBS), penicillin (100 
UI/mL) and streptomycin (100 μg/mL), in a humidified atmo-
sphere incubator with 5% CO2, at the homeostatic temperature of 
37 ◦C. The confluent cells were detached with trypsin (2.5 g/L in 
phosphate-buffered saline without Ca and Mg (PBS, Sigma 
Aldrich, St. Louis, MO, USA)) and centrifuged at 250×g for 10 
min, subsequent to trypsin inhibition. Then, the Hs27 cells were 
re-suspended in complete growth medium, and their concentra-
tion was set to 105 cells/mL with a Bürker-Türk counting cham-
ber (Brand GmbH + CO KG, Wertheim, Germany). On each type 
of sample 100 μL of medium, containing 104 cells, was used. 
Further, the plates containing the cell seeded samples were 
transferred into a humidified incubator, and left for cell adher-
ence. After 5 h, a volume of 400 μL of fresh cell culture medium 
was added in each plate well. Subsequently, the plates were 
transferred in the cell culture incubator, at 37 ◦C, 5% CO2 hu-
midified atmosphere, and the cells allowed to grow for 24 h.  
(b) The hMSCs were subcultured according to manufacturer’s in-
structions, and brought to confluence. The confluent cells were 
detached with trypsin (2.5 g/L in phosphate-buffered saline 
without Ca and Mg (PBS, Sigma Aldrich, St. Louis, MO, USA)) and 
centrifuged at 200×g for 10 min. hMSCs were resuspended in 
complete appropriate culture media (MSCGM human Mesen-
chymal Stem Cell Growth BulletKit™ Medium, Lonza, Basel, 
Switzerland). The cell number was adjusted to 105 cells/mL, 
using a Bürker-Türk counting chamber (Brand GmbH + CO KG, 
Wertheim, Germany). On each sample 100 μL of medium, con-
taining 2 × 103 cells, was spread and the plate was transferred in 
the incubator. After 4 h, 400 μL of fresh cell culture medium was 
added in every well and the plates were transferred in the cell 
culture incubator, at 37 ◦C, 5% CO2 humidified atmosphere. 
2.4.2.2. Cell morphology. Morphological features of the cells cultured 
on the uncoated and coated Ti substrates were inferred by fluorescent 
microscopy using a Zeiss Axioplan microscope (Carl Zeiss AG, Oberko-
chen, Germany) with appropriate filters. The cells were fixed with 4% 
para-formaldehyde dissolved in PBS for 15 min at room temperature. 
After washing three times with PBS, the actin cytoskeleton was stained 
using 100 μL of phalloidin-AlexaFluor546 (Invitrogen, Carlsbad, CA, 
USA) and each sample incubated for 1 h. Further, the samples were 
washed using three consecutive cycles of 15 min, and then incubated 
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with 1 μg/mL of DAPI (4′,6-diamidino-2-phenylindole) for nuclei 
counterstaining. The samples were washed two times with PBS and once 
with double distilled water (15 min for each wash) and mounted onto 
0.17 mm glass coverslips using the Dako (Invitrogen, Carlsbad, CA, USA) 
mounting medium in view of cell morphological investigation. 
2.4.2.3. Cell toxicity by LDH assay. After 24 h of cell culturing, the 
medium supernatant was collected in order to evaluate the cytotoxicity 
of the PBG-based coatings by the lactose dehydrogenase (LDH, Thermo 
Fisher Scientific, Waltham, MA, USA) assay. Into wells with 50 μL of 
medium were added aliquots of 50 μL of LDH assay buffer, and the plates 
transferred into the incubator for 30 min. Then, the reaction was 
terminated by addition of 50 μL of stop buffer. The absorptions were 
read at wavelengths of 490 nm and 620 nm using a Zenyth 3100 
multimode microplate reader (Anthos Labtec Instruments, Salzburg, 
Austria). The cell death was inferred by subtracting the 620 nm values 
from the 490 nm ones. The control of the experiment for LDH activity 
was represented by the fresh complete medium. 
2.4.2.4. Cell proliferation by MTS assay. The cell proliferation on the 
surface of the uncoated and PBG-coated Ti substrate was assessed via 3- 
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium (MTS, Promega Corporation, Madison, WIS, 
USA) assay. First, 400 μL of DMEM was added to each well and incu-
bated for 30 min. Next, 80 μL of MTS containing buffer was added and 
further incubated for 1 h in the incubator. The plates were gently stirred 
and agitated for 1 min at 150 rotations/min. Then, a 120 μL aliquot was 
collected from each sample well and moved into a 96 well plate. The 
absorption was read at a wavelength of 490 nm using the same Zenyth 
3100 multimode microplate reader (Anthos Labtec Instruments, Salz-
burg, Austria). Unless indicated, all the cell culture reagents were ac-
quired from Sigma Aldrich (St. Louis, MO, USA). 
2.4.3. Antibacterial assays 
The antibacterial effect of the samples was carried out in accordance 
with the ISO 22196:2011 standard [59]. The antibacterial efficacy of 
RF-MS PBG-based coatings was tested against both Gram-positive 
(Staphylococcus aureus, ATCC® 6538, Manassas, VA, USA) and 
Gram-negative (Escherichia coli, ATCC® 8739, Manassas, VA, USA) 
strains. S. aureus and E. coli are pathogen agents known to frequently 
cause post-surgery infections in both orthopaedics and dentistry [3, 
60–67]. 
First, the square PBG coated Si substrates were dry-heat sterilized 
(180 ◦C/1 h) and transferred into sterile 6-well plates in the laminar flow 
hood. Suspension of S. aureus and E. coli in nutrient broth (NB) were 
independently prepared to a concentration of 106 colony forming units 
(CFU)/mL by viable cell count. 100 μL of NB, containing 105 viable CFUs 
was layered atop the coated samples and an inert sterile plastic film 
(square with 20 mm side) was placed over the liquid, as described in the 
ISO 22196:2011 standard. The plates were transferred in the incubator. 
After 24 h of incubation, 3 mL of NB were added in each well and the 
plastic film and samples were thoroughly scraped with a dedicated 
sterile rubber scrapper to detach all the bacterial cells that might be 
encapsulated in biofilm (ultrasonication of samples was avoided since it 
can affect the viability of bacterial cells, and thereby, the CFU analysis 
will become inaccurate). 10-fold serial dilutions were prepared for each 
situation, and from each sample dilution two pre-casted plates with 
plate count agar (100 mm diameter) were seeded with 1 mL inoculum. 
After 24 h in the incubator the plates were counted for colonies. The 
number of viable CFU present after 24 h of incubation in the presence of 
the Ag:PBG-PVD, Ga-PBG-PVD or controls were calculated with the 
formula: Viable CFU = 3 × dilution × (average number of colonies on 
the two plates). All materials used in antimicrobial tests were from 
Sanimed International Impex, IVD (In Vitro Diagnostics) (Bucharest, 
Romania) certified producer for medical bacteriology laboratories. 
2.4.4. Statistical analysis 
All in vitro biological experiments were performed (at least) in trip-
licate. The results are presented as arithmetic average ± standard error 
of the mean. The statistical analyses were performed using the unpaired 
Student’s t-tests or one-way Anova followed by a Tukey Kramer post hoc 
test (when appropriate), and the differences were considered significant 
when p < 0.05. 
3. Results and discussion 
3.1. Physical-chemical characterization 
The physical-chemical analysis of the Ga-PBG-PVD coatings was 
partly addressed in our previous work [50]. For this reason, the current 
study will focus predominately on the morphological, structural and 
chemical features of the Ag:PBG-PVD type coating, with additional 
characterization added where appropriate in the case of the 
Ga-PBG-PVD samples. 
3.1.1. Structural characterization 
The FTIR spectra of the Ag:PBG and Ga-PBG targets and deposited 
films are presented comparatively in Fig. 2. All materials featured 
equivalent IR absorption bands, peaking at similar wave number posi-
tions, but with dissimilar intensities. Explicitly, the observed IR can be 
ascribed as follows [47,50,68,69]:  
• ~790–740 cm− 1: symmetric stretching (νs) of P–O–P bridges in the 
Q1P and Q2P phosphate units; 
Fig. 2. Comparative FTIR spectra of the magnetron sputtered (A) Ag:PBG and 
(B) Ga-PBG films and of their corresponding source materials (cathode targets). 
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• ~930–900 cm− 1: asymmetric stretching (νas) of P–O–P bridges in the 
metaphosphate Q2P units; 
• ~1150–1080 cm− 1: νas of the end-of-chain (PO3)2− in the pyro-
phosphate Q1P units;  
• ~1280–1230 cm− 1: νas of non-bridging oxygen (NBO) atoms of 
O–P–O bonds, middle-of-chain (PO2)− , and terminal oxygen bonds 
(P=O) in the metaphosphate Q2P units. 
Both types of PVD film exhibited a lower degree of glass network 
connectivity with respect to each corresponding source material, as 
evidenced by the increase in intensity of the νas Q1P bands at the expense 
of the νas ones appertaining to bonds in Q2P units. It is thus suggested an 
incongruent target-to-substrate atomic transfer of the network glass 
formers (i.e., P), a characteristic of the RF-MS processes [48]. A more 
salient depolymerization was noticed in the case of Ag:PBG-PVD, as 
expected for films deposited under low sputtering pressure regimes [48]. 
The depolymerization induced by this methodology is ideal where 
PBG sacrificial implant coatings are being designed with rapid bio- 
degradation in intercellular fluids, and thus capable of readily 
releasing the antimicrobial agents embedded within their glass matrix. 
Such a feature could be of paramount importance, as the first hours post- 
implantation are known to be critical for preventing infection, while the 
bacteria are still dormant and metabolically inactive, and thereby easier 
to combat [70,71]. 
3.1.2. Cross-sectional morphology analysis 
A FIB prepared lamella was imaged by BF-TEM (Fig. 3A), indicating a 
coating thickness for Ag:PBG-PVD of 46 ± 1 nm. The BF-STEM image 
and the corresponding EDXS mapping suggested a uniform dispersion of 
Ca and scattered distribution of Ag particulates throughout the cross- 
section (Fig. 3B). P was not measured due to overlap of the Pt Kα X- 
ray emission from the deposited Pt band during the FIB lift-out pro-
cedure. The Ag:PBG-PVD thin film (cross-sectional) growth morphology 
appeared granular (Fig. 3A and B). The FE-SEM cross-sectional imaging 
indicated that both the Ga-PBG-PVD ≈400 nm (Fig. 3C) and Ga-PBG- 
PVD ≈1400 nm (Fig. 3D) coatings elicited a smooth growth 
morphology composed of fine columns, characteristic of amorphous 
films deposited by RF-MS [45]. Thereby, the growth morphology of the 
Ag:PBG-PVD films differed significantly from the columnar-type 
observed in the Ga-PBG-PVD layers, which is ascribed to the employed 
argon pressure and substrate temperature regimes, according to the 
Thornton structure zone model [72]. The columnar growth is known to 
be preserved only for low Ag contents (<8 at.%); at higher concentra-
tions, Ag disturbs the columnar growth, segregates and forms agglom-
erates, leading to a granular-type morphology [73]. 
The HRTEM analysis (Fig. 3E) revealed that Ag was efficaciously 
incorporated into PBG matrix by the “dual target consecutive co-sput-
tering” process, in form of spherodised (dark contrast) crystalline nano- 
particles (NPs) with sizes in the range of 4–6 nm. The HRTEM micro-
graph (Fig. 3F) and the corresponding Fast Fourier Transform (FFT) 
diffraction pattern (Fig. 3G) confirmed that the crystalline NPs are fcc- 
Ag (space group: Fm3m) and indexes to fcc-Ag taken along the [0 –1 
1] zone axis. It is suggested that Ag was condensed independently from 
the PBG, creating the dispersion of Ag NPs embedded into the PBG 
matrix. This effect was caused by the unique sputtering configuration 
and parameters used for co-sputtering such that the cp-Ti substrates 
Fig. 3. (A) Cross-sectional BF-TEM micrograph of the 
Ag:PBG-PVD/Ti thin film (thickness of ~46 nm); (B) 
Cross-sectional BF-STEM image of the Ag:PBG-PVD/ 
Ti specimen accompanied by EDXS elemental distri-
bution maps of Ag, Ca, and Ti. (C,D) Cross-sectional 
FE-SEM representative images of the Ga-PBG-PVD/ 
Si coating at a thickness of (C) ≈400 and (D) 
≈1400 nm. (E) HR-TEM micrograph of an Ag:PBG- 
PVD/Ti thin film FIB lamella, highlighting the even 
dispersion of Ag nano-crystals within an amorphous 
PBG matrix. (F) HR-TEM image of a single silver 
nano-crystal, where (G) illustrates the accompanying 
FFT of the region marked in (F). The FFT presented in 
(G) indexes to Ag [0 –1 1].   
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were independently rotated past both the PBG and Ag targets allowing 
for consecutive and repetitive condensation of a PBG followed by Ag at 
minimal radio-frequency deposition power of 5 W (see Section 2.2). 
3.1.3. Surface morphology analysis 
The AFM surface morphology analysis (Fig. 4i-A-H) was performed 
for films deposited on the topologically defect-free mirror-polished Si 
substrates with RRMS values < 0.1 nm (Fig. 4i–A). This allowed for the 
identification of the morphological features of the films independently 
of those of the substrate. The Ti substrates, even if generally smooth 
(RRMS ≈6 nm) were found to contain sporadic craters (data not shown), 
as a result of the polishing process, due to the softer nature of Ti with 
respect to Si. The Ag:PBG-PVD films had a granular surface morphology 
consisting of round-shaped small particulates, on top of which, were rare 
larger-sized particles (Fig. 4i–B). Their surface (RRMS) roughness was 
~2 nm. The high magnification FE-SEM investigations (Fig. 4ii-A′) 
confirmed the presence of the two type of particles, of ~9 and 30–65 nm, 
with the larger ones strongly enriched in Ag (Fig. 4ii-B′). The formation 
of larger Ag particulates on the sample surface, at the end of the coating 
process, with respect to those immersed in the film matrix (Fig. 3E) is not 
unprecedented [73]. It is believed that during a constant deposition 
process, marked by a continuous influx of target sputtered species, the 
nucleated Ag NPs will be enwrapped, and their growth will be hindered 
[73]. However, at the end of the deposition, when no more PBG ad-a-
toms are arriving, the silver will be allowed to migrate and agglomerate 
to lower surface energy sites [73], giving rise to larger formations. The 
Ga-PBG-PVD coatings (Fig. 4i-C–F; Fig. 4ii-C’) presented the familiar 
morphology of the sputtered PBG layers, featuring surface pits [47,50]. 
The surface pits are attributed to an inadequate diffusion of the arriving 
ad-atoms, higher volatility of P2O5 with respect to the other glass con-
stituents, and self-shadowing phenomena [47,50]. With the increase of 
the Ga-PBG-PVD film thickness, the surface pits become larger 
(increasing from ~300 to ~570–1100 nm) and deeper (the depth aug-
menting from ~4 to ~19 nm) (Fig. 4i–G,H), suggesting that the 
self-shadowing role becomes more prominent, with the pits created in 
earlier deposition steps further impeding the diffusion of sputtered 
species on the growing film surface. This resulted in an increase in the 
surface roughness (RRMS) from ~1.5 nm (irrespective of size of scanned 
area) to ~8 and 12 nm (for scanned surface areas of 10 × 10 and 2 × 2 
μm2), in the case of Ga-PBG-PVD≈400 nm and Ga-PBG-PVD≈1400 nm, 
respectively. 
3.1.4. Chemical analysis (EDXS and XPS) 
The composition of the as-fabricated cathode targets was confirmed 
by EDXS-SEM (Table 1 vs. Fig. 5i–A,B). The oxide concentration of the 
PVD films (reconstituted based on the EDXS-STEM and EDXS-SEM 
elemental quantitative analyses for the Ag:PBG-PVD and Ga-PBG-PVD 
films, respectively) indicated a loss of P2O5 with respect to the source 
materials, as hinted by the FTIR spectroscopy results (Fig. 2). The Ag: 
PBG-PVD film consisted of 64.5 wt% PBG and 35.5 wt% Ag. 
The target-to-substrate stoichiometric deviations and their causality 
were well-documented in our previous studies [46–48,50], undertaken 
to define a reproducible magnetron sputtering protocol for the deposi-
tion of PBG layers. Briefly, these compositional changes are primarily 
the result of preferential sputtering effects due to differential scattering 
of constituent elements by the working gas as well as to variations in 
dissociation energies of the target structural units and atoms. The 
re-sputtering of deposited atoms by the high energy incident sputtered 
Fig. 4. (i) AFM images of the mirror polished Si substrate (A) before and (B–F) after coating with (B) Ag:PBG-PVD, (C,E) Ga-PVD-PBG≈400 nm, and (D,F) Ga-PVD- 
PBG≈1400 nm type layers, recorded on surface areas of (A–D) 10 × 10 μm2 and (E,F) 2 × 2 μm2. The RRMS value is inserted in each corresponding AFM micrograph. 
(G,H) Comparative height profiles of the corresponding dashed lines drawn in the (E) and (H) AFM images, respectively. (ii) FE-SEM images of the (A′) Ag:PBG-PVD 
and (C′) Ga-PVD-PBG≈1400 nm type layers grown on mirror polished Ti substrates. (B′) Point EDX spectra acquired for the Ag:PBG-PVD/Ti sample at the zones 
highlighted in (A′): film matrix region - red line; light-coloured nano-particle: cyan line. (For interpretation of the references to colour in this figure legend, the reader 
is referred to the Web version of this article.) 
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units (atoms or clusters) should be also more pronounced at low working 
gas pressures and/or high deposition powers. In such a case, the P 
content is the most susceptible to being ill-replicated in the films, since P 
requires more energy to form stable oxide bonds (i.e., 2983 kJ mol− 1) 
with respect to the other glass elements [48], leading to weaker surface 
bonding, and therefore easier susceptibility to re-sputtering. This 
behavioural pattern seems to support the lower P2O5 content of the Ag: 
PBG-PVD coatings (deposited at lower argon pressure of 0.36 Pa and 
higher sputtering power of 100 W) with respect to the Ga-PBG-PVD ones 
(deposited at a higher argon pressure of 1.33 Pa and lower sputtering 
power of 60 W) (Table 2). 
The XPS analysis was used to assess the chemical state of the anti-
microbial agents and the surface structure of the sputtered glass films. 
The binding energy location of the Ag 3d5/2 and Ag 3d3/2 photoelectron 
emission lines at 368.11 and 374.15 eV (Fig. 5ii-A) was most closely 
associated with metallic Ag [74–78], as expected from condensation in 
the inert argon environment and as clearly indicated by TEM analysis. 
The binding energy of the Ga 2p3/2 (1119.22 eV) and Ga 2p1/2 (1146.11 
eV) (Fig. 5ii-B) confirmed their complete oxidation [79–81]. 
The position of the P 2p3/2 line at 134.11–134.55 eV was found to be 
at an intermediate location between the associated position for meta- 
and pyro-phosphate structures (Fig. 5ii-C,D), suggesting the combined 
presence of metaphosphates (PO3) and pyrophosphates (P2O7) [46,74, 
82,83]. The decrease of the P 2p binding energy, recorded in the case of 
Ag:PBG-PVD, indicated an increase in the network modifier concentra-
tion, in good agreement with the EDXS analyses (Fig. 5i). In such a case, 
two outcomes are foreseen [84–86]:  
(1) The network connectivity of the PBG will be decreased, leading to 
the generation of NBOs. This depolymerization process of the 
phosphate chains will be accompanied by a transfer of electronic 
changes, and consequently an increase of electronic density 
around P and therefore, a decrease in the P 2p binding energy. 
(2) At a high concentration (typically ≥50 mol%) of network modi-
fiers the disruption of the P=O linkages can be expected. One 
should note that the charge distribution in the P=O bond is dis-
placed toward oxygen, suggesting an electron density deficiency 
around P and thereby, a reduction of the nuclear charge shield-
ing. When the P=O is cleaved, the electron density around P may 
increase, resulting in the decrease of the P 2p binding energy. 
Both hypotheses are supported by a more drastic decrease of the 
asymmetric stretching IR absorption bands of middle-of-chain (PO2)−
and terminal oxygen bonds (P=O) in the metaphosphate units, noticed 
in the case of Ag:PBG-PVD with respect to Ga-PBG-PVD (Fig. 2). 
Previous investigations showed that polymerisation by production of 
Fig. 5. (i) Comparative experimental oxide compositions of the magnetron sputtered (A) Ag:PBG and (B) Ga-PBG films and of their corresponding source materials 
(cathode targets), as estimated based on EDXS-type analyses. The results are presented as mean ± standard error of the mean (n = 4). *Ref. [50]. (ii) XPS spectra of (A 
′) Ag 3d, (B′) Ga 2p, (C′, D′) P 2p and (E′, F′) O 1s photoelectron core level peaks, indicative of surface bonding state, recorded for the (A′, C′, E′) Ag:PBG and (B′, D′, 
F′) Ga-PBG PVD films. 
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metaphosphate species led to increased wettability, water adsorption 
and therefore degradation [14]. 
Furthermore, the O 1s core level can be deconvoluted with two 
components [87], one positioned at higher binding energies, assigned to 
the bridging P–O–P oxygen atoms, and a second one, situated at a lower 
binding energies, including two types of terminal/non-bridging oxygen 
atoms (P=O and P–O–M, where M = network modifier). The chemical 
shift of the latter two is too small to be reasonably separated under the 
employed measurement (resolution) conditions. The peak separation 
procedure applied to the O 1s core level (Fig. 5ii-E,F) confirmed the 
higher depolymerization degree of the Ag:PBG PVD films, having a NBO 
content of ~67%, with respect to Ga-PBG-PVD which amassed ~59% 
NBOs. 
3.1.5. Surface energy measurements 
Surface free energies of the uncoated and PBG-coated cp-Ti sub-
strates were measured before and after degradation for 4 h in H2O. The 
application of the PBG coating on mirror-polished cp-Ti resulted in a 
super-hydrophilic surface (i.e., the CA with water being equal or close to 
zero degrees), with the complete spreading of water on the specimens 
(Fig. 6A). This behaviour can be connected with high solubilisation (by 
hydrolysis) ability of these particular PBG formulations, with the water 
molecules being rapidly absorbed and reacted leading to the formation 
of OH− groups on the coating surface [88]. The presence of the surface 
pits (Fig. 4) may be a concurrent factor, allowing the infiltration of 
liquid inside coatings through the capillary action [88]. After 4 h of 
soaking in water the CA values remain unaltered (Ga-PBG-PVD 1400 
nm) or increased to 10◦ (for Ag:PBG-PVD) and 26◦ (for Ga-PBG-PVD 
400 nm). Hydrophilic-type implant surfaces as these are known to 
facilitate the cells adhesion, migration and proliferation, to the benefit 
of a fast bone tissue regeneration [89]. 
The hydrophilicity of the PBG coatings was additionally supported 
by the superior surface free energy values (Figs. 6B), 71–78 mN/m, 
compared to the uncoated mirror polished cp-Ti (~44 mN/m). 
3.2. Preliminary in vitro biological assessments 
3.2.1. Degradation and ion release profiles 
The thinness of the Ag:PBG-PVD films (≈46 nm) limited the mass of 
the film to below the reliable resolution of the microbalance and 
therefore the mass loss/degradation profile could not be measured. The 
mass loss profiles for Ga-PBG-PVD (≈1400 nm) were significantly 
different in DI water, NB and DMEM as presented in Fig. 7A. Specifically, 
the fastest degradation and leaching of PBG components was observed in 
NB for which Ga-PBG-PVD was fully dissolved following 8 h of immer-
sion. It should be noted that all variations of PBG-coated samples were 
extracted clean from the NB solution, as featured by the glossy mirror- 
polished surface of the metallic Ti substrate, without traces of film 
(and its specific colour) on the entire specimen surface. In DI water the 
coating exhibited slightly different values with similar trends, progres-
sively increasing up to 8 h, followed by stabilisation at 72% mass loss. 
Degradation was markedly different in DMEM where a reduction in 
mass of 16% was observed after 1 h of immersion, remaining stable at ca. 
20% thereafter up to the final measurement time of 24 h. This could 
have been attributed to the following two factors: (i) the higher pH 
buffering capacity of DMEM and (ii) formation of a shielding layer of 
adsorbed organics, amino-acids and serum proteins on the surface which 
is well-documented in literature to cause a lag in surface dissolution 
[90]. 
Fig. 6. (A) Average water contact angles and representative captured screen 
shots and (B) surface free energy values recorded for (1) mirror-polished cp-Ti 
and (2, 3) Ag:PBG-PVD, (4, 5) Ga-PBG-PVD≈400 nm and (6, 7) Ga-PBG- 
PVD≈1400 nm films, (1, 2, 4, 6) as-prepared and (3, 5, 7) after 4 h of degra-
dation in water. Note: γT – total surface free energy, γp – polar component, and 
γd – dispersive component. 
Fig. 7. (A) Mass loss temporal profiles recorded for Ga-PBG-PVD≈1400 nm 
samples in DI water, NB and DMEM (*p < 0.05, one-way ANOVA followed by 
Tukey Kramer’s post hoc test). (B,D) FE-SEM images of the Ag:PBG-PVD and 
Ga-PBG-PVD≈1400 nm layers deposited onto mirror-polished Ti, soaked in 
DMEM solution for 24 h. (C) Point EDX spectra collected in the zones high-
lighted with arrows in (B), for the Ag:PBG-PVD/Ti thin film degraded for 24 h 
in DMEM. 
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Any hypothesis of biomineralization occurring here (i.e., formation 
of amorphous calcium phosphate deposits which could crystallize in 
time into a carbonated hydroxyapatite) in such a short period of time (i. 
e., 1 day) on the surface of PBG layers, thereby stalling their degradation 
in DMEM, should be excluded. PBGs are relatively high-solubility ma-
terials [9,14], and biomineralization has only been reported in a single 
case by Gayathri Devi et al. [91]. However, this took place for bulk PBG 
specimens after 20 days of immersion in a testing medium with higher 
Ca/P molar ratio (i.e., Kokubo’s simulated body fluid, Ca/P = 2.5 [92]) 
with respect to the complex organic-inorganic DMEM medium (Ca/P 
≈1.99) [93]). 
The FE-SEM & EDXS surface analyses (Fig. 7B–D) confirmed that no 
calcium phosphate deposits were formed. The morphology of calcium 
phosphates grown in biomimetic conditions is an unambiguous one, 
consisting of acicular needles agglomerated into spheroids with sizes in 
the micrometre range [90,92]). Instead, the FE-SEM images have indi-
cated the remaining topography of the sputtered layers, and, their 
original globular and pitted morphology, for both Ag:PBG-PVD (Fig. 7B) 
and Ga-PBG-PVD (Fig. 7D), respectively (Fig. 4ii-A′,C’). Signs of film 
erosion were also evident, as well as cracks through which the Ti sub-
strate was visualised (Fig. 7 B vs. Fig. 7C). These film cracks are known 
to occur, usually associated with the drying process of the soaked 
samples [94], then to a preferential local film dissolution. 
The ion release profiles for P, Ca, Mg, Na, Ag and Ga in DI water, NB 
and DMEM are presented in Fig. 8. The overwhelming presence of P, Ca, 
Mg and Na within DMEM and NB compared to the low volume of Ag: 
PBD-PVD within the thin film prevented reliable detection of the listed 
ions. As such only Ag2+ could be quantified. Degradation in DI is a 
standard approach for assessing degradation of bio-resorbable glasses to 
isolate the hydrolytic dissolution mechanisms and to determine the ef-
fect on coating stability relative to compositional/structural modifica-
tions [95–97]. The ICP-MS results suggested that the glass was entirely 
dissolved by 1 h (P ≈6 ppm; Ca ≈2 ppm; Mg ≈1.1 ppm; Na ≈2.5 ppm; Fe 
≈0.5 ppm), showing no further degradation up to 24 h. There was no 
identifiable Ag2+ release in DI water or DMEM suggesting that metallic 
silver was insoluble at the employed testing conditions. In contrast, in 
NB, Ag was progressively released following dissolution of the glass 
matrix for which concentration ranged from 3 to 9 ppm, over the 1–24 h 
period. 
The ion release profiles for Ga-PBG-PVD films were well-aligned with 
mass loss results presented in (Fig. 8). The PBG components (i.e., P, Ca, 
Mg, Na and Ga) were rapidly released in DI water and NB during the first 
4 h of incubation. In DMEM the ion release profiles were significantly 
lower than found in DI water and NB (exemplified by the dissolution of 
phosphate glass backbone to P ions which ranged from ~57, ~263 and 
~54 ppm in DI water, NB and DMEM respectively). Ga3+ ion released 
concentrations in DI water, NB and DMEM were 5.5, 27.3 and 3.7 ppm, 
respectively. 
Although both DMEM and NB are media with important organic 
components, they each induce different film dissolution trends. This 
effect can be attributed to the decrease in pH typically observed when 
PBG dissolves in aqueous media to form phosphoric acid. This is com-
bined with the higher acid buffering capacity of DMEM, which is 
designed to maintain pH value of 7.25 for up to 72 h when cells are 
cultivated in a 5% CO2 atmosphere. As the microbiology nutrient broth 
contains chloride ions (with respect to DI) and no pH buffer (with 
respect to DMEM), it will lead to a faster glass dissolve and readily 
release of ionic constituents. The varying dissolution speeds in NB 
(observed here) and the wide variety of cell culture media (reported in 
literature) is problematic as it could likely foster the occurrence of 
misleading in vitro antimicrobial studies. As shown here media proper-
ties can lead to higher degradation and thereby a higher concentration 
of released therapeutic ions. Whilst a methodology does not yet exist to 
truly mimic the biological environment, continual development of in- 
depth testing methods is required from the biomaterials community. 
The opinion of the authors is that a significant development step in 
degradation/ion release testing could be to use a complex standard 
DMEM with 10% fetal bovine serum, therefore better mimicking the 
environment found in vivo, instead of deionized water or other pure 
inorganic solutions such as Kokubo’s simulated body fluid or TRIS-HCl 
buffer. A modification to the antibacterial assay ISO 22196:2011 
could also be envisaged by replacing the classic nutrient broth with the 
same DMEM fetal serum supplemented solution (used for the cyto-
compatibility tests). This could allow for a unitary testing and a better 
understanding of biomaterials behaviour, leading to a more reliable 
selection of material candidates for future in vivo studies. However, an 
important aspect needs to be considered when designing an implant 
coating. As bacteria develop in the proximity of the implant the envi-
ronment will become more acidic, causing an increase in film dissolution 
and release of therapeutic ions, which will accelerate the antimicrobial 
activity required. 
The remarkable property of PBGs to have a low pH acting as a switch 
for dissolution resulting in therapeutic ions released from the glassy 
network, might prove of extreme importance since it is well-known that 
conventional antibiotics lose their potency in the acidic environments as 
a result of microbial infections and bacteria metabolism. The potential 
Fig. 8. P, Ca, Mg, Na, Ag and Ga ion release temporal profiles of Ag:PBG-PVD and Ga-PBG-PVD implant-type coatings in samples in DI water, NB and DMEM.  
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to have a “delivery on demand” therapeutic ion system, when the an-
tibiotics become overwhelmed by bacteria proliferation, could prove of 
great interest for healthcare. 
3.2.2. In vitro cytocompatibility assays 
Human fibroblast (Hs27) and mesenchymal stem (hMSC) cells were 
cultured for 24 h on uncoated cp-Ti and cp-Ti coated with Ag:PBG-PVD 
and Ga-PBG-PVD-based layers to assess cytocompatibility. Due the 
opaque nature of the studied specimens, the cell morphology was 
observed by fluorescent microscopy. Cell proliferation (for both Hs27 
and hMSC) and cell death (for Hs27) were assessed by MTS and LDH 
tests, respectively. 
The morphology of the cells grown on PBG implant-type coatings 
presented all the hallmarks of a healthy cytoskeleton and nuclei. Hs27 
cells were well-spread on all PBG coating surfaces and retained the 
characteristic morphology of their actin cytoskeleton (Fig. 9A–D). The 
nuclei were normal, without shape, dimension and genetic material 
condensation anomalies. Lack of micronuclei were noticed. 
The MTS tests suggested that Hs27 presented cellular proliferation 
upon all Ag and Ga containing PBG coatings (Fig. 9E). Cells proliferated 
with 100% (polycarbonate control, Ga-PBG-PVD≈400 nm and Ga-PBG- 
PVD≈1400 nm), 85% (uncoated cp-Ti) and 56% (Ag:PBG-PVD) 
compared to the number of seeded cells. Statistical analysis indicated 
significant differences (p < 0.05, one-way Anova followed by Tukey 
Kramer’s post hoc test) between polycarbonate control vs. cp-Ti control, 
both controls vs. Ag:PBG-PVD, and Ag:PBG-PVD vs. Ga-PBG-PVD layers. 
No cytotoxic effects of any Ag or Ga containing PBG coatings were 
observed as a consequence of the ionic release of Na, Ca, P, Mg, Fe and 
Ag/Ga ions, relative to the controls (polycarbonate and cp-Ti) (Fig. 9F). 
The Ag:PBG-PVD layers did however lead to a lower cell proliferation 
rate with respect to control, yet did not provoke cell death. While 
assessing the activity of lactate dehydrogenase (LDH), a noteworthy 
effect was signalled. Specifically, the Ga-PBG-PVD films elicit lower 
values than the blank leading to the conclusion that Ga ions released into 
the testing solution caused a degree of inhibition of this specific enzyme. 
The hMSCs grown on PBG implant-type coatings presented a 
morphology typical for the cell line. The hMSCs retained their shape, 
were well-spread on the sample surfaces, having healthy lamellipodia 
and filopodia, and a normal distribution of actin microfilaments in the 
cytoskeleton (Fig. 10A–C). Only rare cells undergoing division were 
rounded. The nuclei had typical ovoid shape, with normal dimension 
and condensation of chromatin. No micronuclei were observed. The 
MTS tests suggested cellular proliferation on both Ag and Ga containing 
PBG layers (Fig. 10D). However, a delayed hMSCs proliferation was 
noticed for the Ag:PBG-PVD when compared to the bare cp-Ti and Ga- 
PBG-PVD≈1400 nm, similar to the Hs27 cells. 
Overall, the morphological analysis of cells grown on these layers in 
conjunction with the cell proliferation data showed that these films were 
cytocompatible. Regarding the potential toxicity of the antimicrobial 
agents (Ag and Ga) in some systems (e.g., nephrotoxicity, haemotox-
icity), it should be highlighted that the PBG films leach a very small 
amount of Ag and Ga in total. Even in the event of total dissolution of the 
films, the amount of Ga released for a dental fixture (typically 3.75 mm 
thick and 11 mm long) covered with ≈1400 nm and ≈400 nm of Ga- 
PBG-PVD film would be approximately 200000–700000 times less 
than the Ga amount in the case of a course of Ga nitrate treatment for 
hypercalcemia [98–100] that has been shown to be a major risk in 
causing renal function impairment. 
Fig. 9. (A – D) Morphology of Hs27 cells grown for 
24 h on (A) uncoated cp-Ti and (B) Ag:PBG-PVD, (C) 
Ga-PBG-PVD≈400 nm and (D) Ga-PBG-PVD≈1400 
nm coated cp-Ti. Actin microfilaments of the cell 
cytoskeleton were stained with phalloidin- 
AlexaFluor596 (red), whilst the cell nuclei were 
counterstained with DAPI (blue). (Bar charts) 
depicting the (E) cell proliferation and (F) cell 
toxicity at 24 h, obtained by MTS assay (values are 
normalized as percentages relative to the seeding cell 
number) and LDH assay (the values are shown in 
arbitrary absorption units), respectively for: (1) pol-
ycarbonate biological control, (2) Uncoated cp-Ti and 
(3) Ag:PBG-PVD, (4) Ga-PBG-PVD≈400 nm and (5) 
Ga-PBG-PVD≈1400 nm coated cp-Ti. (For interpre-
tation of the references to colour in this figure legend, 
the reader is referred to the Web version of this 
article.)   
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3.2.3. Antibacterial activity tests 
The antimicrobial efficacy of Ag:PBG and Ga-PBG PVD layers was 
assessed by quantification of viable colony forming units (CFU) after 6 
and 24 h of culture with S. aureus (Fig. 11A) and E. coli (Fig. 11B). When 
culturing on the uncoated substrate, a progressive proliferation of bac-
teria (up to 3-log increase at 24 h) was observed, irrespective strain type. 
The bactericidal effect of Ag:PBG and Ga-PBG layers was evidenced 
for both Gram-positive and Gram-negative bacteria. Similar antimicro-
bial trends were shown at both time points for all variants of PVD films 
in relation to Gram-negative E. coli where CFUs were reduced by 2 log 
(after 6 h) and 2.5 log (after 24 h) with respect to the initially seeded 
CFUs. In comparison to the uncoated substrate, a 3.5-log and 5-log E. coli 
reduction was recorded at 6 and 24 h, respectively. In the case of Gram- 
positive S. aureus, the antibacterial efficacy increased in the order Ag: 
PBG-PVD < Ga-PBG-PVD≈400 nm < Ga-PBG-PVD≈1400 nm, at all-time 
points. The proliferation of S. aureus was drastically reduced for the Ga- 
containing coatings, whereby a 5 and 6 log-reduction was recorded after 
24 h in the case of Ga-PBG-PVD≈400 nm and Ga-PBG-PVD≈1400 nm, 
respectively, with respect to the uncoated substrate. The result suggests 
that the intensity of the effect can be controlled by varying the Ga-PBG- 
PVD film thickness (and thereby, the amount of therapeutic ions to be 
released). 
If Ga has not been yet incorporated into calcium phosphates or 
bioactive glasses, a comparison on the antimicrobial effect of Ag parti-
cles of similar sizes (as employed in this study) can be attempted (even 
though it should be mentioned that the testing methods vary). Kirma-
nidou et al. [101] investigated the acceptable cytocompatible and 
antibacterial size range of Ag NPs applied to Ti6Al4V by electrochemical 
deposition to distribute particles ranging from 5 to 30 nm. They 
concluded that the 5–30 nm NPs had a pronounced antibacterial efficacy 
(at 24 h) with respect to Porphyromonas gingivalis and Prevotella inter-
media strains (inferred by a serial dilution spotting assay), while only the 
5 nm NPs induced a concentration-dependent decrease in bone osteo-
sarcoma (Saos-2) cell proliferation rates at 48 h, followed by recovery at 
72 h. Furthermore, Surmeneva et al. [102] produced a tri-layer system – 
a 1.5 μg/cm2 dispersion of electrophoretic deposited Ag NPs with sizes 
of 70 ± 20 nm, sandwiched between two magnetron sputtered calcium 
phosphate-based coatings – and suggested antibacterial efficacy against 
E. coli (following a semi-quantitative turbidity test) subsequent to a 1/3 
release of Ag NPs over a 3-day period in Phosphate Buffered Saline so-
lution. The structure presented a good cytocompatible response in 
human bone osteosarcoma (MG-63) cell cultures. By utilising the 
photosensitivity of Ag to light, Range et al. [103] incorporated up to 1.8 
wt% of either Ag + or elemental Ag0 (in dark or ambient light conditions, 
respectively) into calcium phosphate ceramics and compared their 
antibacterial properties against E. coli to Ag3PO4. A silver loading of 
~0.89 wt% in the calcium phosphate coating, led to a 20 μg over time 
release in water, leading to the formation of inhibition zones similarly to 
Ag3PO4, which is indicative of an antibacterial effect. Satisfactory 
cytocompatibility in human epithelial cervical cancer (HeLa) cell cul-
tures (unlike the case of Ag3PO4) was obtained. Chernozem et al. [104] 
manufactured intricate structures by the coating of TiO2 nanotubes with 
electrophoretic deposited hybrid composites consisting of Ag and cal-
cium phosphate NPs, which showed a promising antibacterial efficacy 
against S. aureus. 
The antimicrobial effects of both Ag and Ga are dose dependent [34, 
105]. Two mechanisms for Ag NPs mechanisms are possible, as reviewed 
elsewhere [105–107]: (i) direct contact (leading to the damage of bac-
terial cell membrane, and leakage of cell contents), enhanced for 
nanoparticles with sizes lower than 10 nm [106]; and (ii) by ion-release 
(upon penetration into the cytoplasm of cells, the ions will interact with 
proteins, lipids, and DNA, or by generating reactive oxygen species 
which can damage proteins and nucleic acids [105,107]. Ga3+ has sig-
nificant potential as an effective antimicrobial element, due to what is 
currently referred as a the “Trojan horse” effect, by disrupting the ion 
metabolism of bacteria [34,50,108]. Ga3+ enters the bacteria by disguise 
through Fe3+ uptake systems, being masked via similar trivalancy and 
ionic radius. Iron is part of many cellular enzymes, and is beneficial to 
the cell for its ability to change redox state, between 2+ and 3+. Iron is 
found as well in many intracellular bacterial enzymes and is involved in 
Fig. 10. (A – D) Morphology of hMSC cells grown for 24 h on the (A) uncoated and (B) Ag:PBG-PVD and (C) Ga-PBG-PVD≈1400 nm coated cp-Ti. Actin micro-
filaments of the cell cytoskeleton were stained with phalloidin-AlexaFluor596 (red), whilst the cell nuclei were counterstained with DAPI (blue). (D) hMSC pro-
liferation at 24 h, as assessed by a MTS test. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of 
this article.) 
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crucial mechanisms such as DNA synthesis or cell metabolism (cyto-
chromes, catalases, peroxidases). In contrast Ga3+ cannot be reduced to 
2+ leading to detrimental cellular uptake of Ga over Fe. 
As seen in the data presented above, Ga ions affect the activity of 
LDH in human cells, an enzyme involved in the energy generation by 
anaerobic glycolysis, NAD (nicotinamide adenine dinucleotide) system 
interaction that can transfer and deal with H− (hydride) ions being 
linked with the reactive oxygen species equilibrium). The LDH enzyme, 
found in both S. aureus and E. coli [109,110], could be disrupted along 
with many cellular processes that overwhelms the bacteria ability to 
repair and survive, thus resulting in an important bactericidal effect. 
In the human blood, iron is found in concentrations ranging from 0.6 
to 1.7 mg/L− 1 circulating complexed with transferrin, an iron trans-
porting protein. Thus, even the smallest Ga released concentration at 24 
h (i.e., 3.7 mg/L− 1, as tested in DMEM), is 10–100 fold larger than the 
free iron content found in blood. Therefore, the Ga ions can competi-
tively enter the bacterial cells and replace iron in key enzymes. The 
smaller impact observed in Gram negative bacteria can be attributed to 
their more complex wall, which slows down the Ga ion penetration and 
redundant efflux mechanisms that overall lead to a lower intracellular 
Ga concentration. 
Furthermore, in previous studies, Stuart et al. [14,26] demonstrated 
controlled ionic release rates of all constituents within PBG thin films 
until the point of complete dissolution. The continuous shedding of the 
surface may be an additional factor preventing bacterial attachment. 
Therefore, PBG films have the capacity to combat both initial attach-
ment and subsequent biofilm formation onto medical implants, ranging 
from dental fixtures to hip stems. 
Due to the tailor-ability of these coatings the quantity of therapeutic 
ions released in the body from such a new generation of implant coat-
ings, can be controlled to be maintained at values 1000 times lower than 
where cytotoxic effects would appear. 
By collective assessment of in vitro cytocompatibility and antibacte-
rial testing, the results suggested that the Ga-PBG-PVD layers conferred 
superior bio-functionality to the implant-type surfaces. Furthermore, 
Ga3+ has demonstrated therapeutic effects on osteogenic cells, pre-
venting bone resorption through inhibition of osteoclast activity and 
stimulation of osteoblasts [111]. Moreover, osteogenic ions such as Ca, P 
and Mg may eventually lead to enhanced proliferation and stimulation 
of pre-osteoblastic cells [112]. The controlled dissolution will allow for a 
time limiting layer to fight infection prior to revealing a sub-osteogenic 
layer such as hydroxyapatite or bioactive silicate glass. Thus, based on 
the presented information, we suggest for that Ga-PBG-PVD films are a 
promising and safe solution for the future development of advanced 
medical implants. Whilst encouraging here, further testing is still 
necessary in order to prove their complete suitability (when coupled 
with osteogenic layers). 
4. Conclusions 
Active agents of Ag and Ga were incorporated into PBG thin-film 
matrices to control the release of antimicrobial (Ga, Ag) and osteo-
genic (Ca, P, Mg) elements for application in next generation implant 
coatings. As such, a novel methodology, labelled here as “dual target 
consecutive co-sputtering”, was shown by the TEM and XPS to suc-
cessfully form 5 nm Ag clusters contained within a 46 nm thick PBG 
coating layer onto commercially pure Ti. Thereby, this advanced 
deposition variation showed good promise, and can be extended to 
foster fabrication of other metal-glass composites in biomedicine, but 
not limited to it, with potential utilization spanning to electronic thin 
film applications. On the other hand, Ga is reported to be effective in its 
ionic, Ga3+ form, and therefore a conventional approach of sputtering 
from a PBG containing Ga2O3 as a network modifier was employed to 
deposit 400 and 1400 nm thick coating layers. 
Dissolution and ICP-MS ion release profiles were obtained over a 24 
h period in various media [Dulbecco’s Modified Eagle’s Medium 
(DMEM), nutrient broth (NB), and deionized (DI) water] and high-
lighted a critical point for academic and industry wide investigation of 
standardised ISO methods, whereby a well-known disparity exists be-
tween dissolution behaviour in the wide variety of available in vitro 
media used. Shown here, Ag ions were released solely in NB (commonly 
used in antibacterial assays such as ISO 22196:2011) to maximum 
amounts of 9 ppm, whilst in DMEM (medium used for cytocompatibility 
assays, as outlined by ISO 10993-5:2009), no ionic release of Ag was 
identified (possibly being below the sensitivity limit). The ability to 
dissolve Ag nano-particles was attributed to the combined of presence 
chloride ions and the inadequate buffering ability of NB as compared to 
DMEM. The 1400 nm Ga containing coating showed at 24 h active Ga 
release of 6, 27, and 4 ppm in the DI water, NB and DMEM media, 
respectively. The PBG dissolution and therapeutic ions release seems to 
be linked to pH balancing capability, and thereby, a thorough study 
should be carried out in the near future, prior to the next phase of in vivo 
testing. The superior pH balancing activity of the intercellular envi-
ronment might cause a reduced initial antimicrobial performance. 
However, one should also note that upon bacteria proliferation the local 
tissue environment changes dramatically, due to inflammation and 
leucocytes action, as a consequence causing a decrease in the pH 
balancing capacity of in vivo medium. Such conditions begin to be 
similar to ones met in the case of bacteria grown in nutrient broth, which 
is created to give such microorganisms the best chance for development. 
To exemplify the functionality, both types of coating were tested for 
cytocompatibility (in human fibroblast – Hs27 – and mesenchymal stem 
– hMSC – cells) and antibacterial efficacy (against S. aureus and E. coli 
strains) at 24 h. All Ag:PBG and Ga-PBG PVD samples were 
Fig. 11. Time evolution of the antibacterial activity of the Ag:PBG-PVD and Ga- 
PBG-PVD implant-type coatings against (A) S. aureus and (B) E. coli. The data 
are represented as logarithmic values of CFU mL− 1 of bacterial cells. 
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cytocompatible, although signs of delayed (Hs27)/hindered (hMSC) cell 
proliferation were recorded in the case of Ag:PBG-PVD≈46 nm thin 
films with respect to the bare Ti control, whilst even in the case of the 
thicker (≈1400 nm) Ga-PBG-PVD coatings, no such events were noticed. 
Therefore, it is suggested that the use of much thicker Ag:PBG-PVD films 
could be suboptimal, whilst thicker Ga-PVD-PBG coatings could be 
further (and perhaps, safely) explored. Antibacterial efficacy at 24 h as 
assessed by measurement of CFUs showed promise relative to both Gram 
positive (S. aureus) (6-log reduction for Ga-PBG-PVD≈1400 nm, 5-log 
reduction for Ga-PBG-PVD≈400 nm and 4-log reduction for Ag:PBG- 
PVD≈46 nm) bacterial strains and Gram negative (E. coli) (5-log 
reduction for all PVD coatings) with respect to the uncoated Ti. 
Thereby, the combined preliminary cytocompatibility – antimicro-
bial studies showed that both coating solutions have the potential to be 
used as sacrificial layers to counteract implant infection due to surface 
contamination. The results within this study could contribute to paving 
the way for the development of fully tailorable therapeutic films with 
widespread applicability in next generation endo-osseous implants such 
as hip stems or dental implants. Our future research studies will continue 
on the basis of these established premises. 
CRediT authorship contribution statement 
B.W. Stuart: Conceptualization, Methodology, Investigation, 
Writing – original draft, Writing – review & editing. G.E. Stan: 
Conceptualization, Methodology, Investigation, Writing – original draft, 
Writing – review & editing, Resources, Supervision. A.C. Popa: Meth-
odology, Investigation. M.J. Carrington: Investigation, Writing – re-
view & editing. I. Zgura: Methodology, Investigation. M. Necsulescu: 
Methodology, Investigation. D.M. Grant: Writing – review & editing, 
Resources, Supervision, Funding acquisition. 
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgements 
This work was supported by the Engineering and Physical Sciences 
Research Council [grant number EP/K029592/1] via the Centre for 
Innovative Manufacturing in Medical Devices (MeDe Innovation). G.E.S. 
and A.C.P are grateful for the financial support of the Romanian Na-
tional Authority for Scientific Research and Innovation, CNCS- 
UEFISCDI, in the framework of projects PN-III-P1-1.1-TE-2016-1501 
and PN-III-P1-1.1-TE-2019-0463, as well as to the Core Programme 21 
N. We would also like to acknowledge Dr. Chris Parmenter and Dr. Mike 
Fay for their assistance in FIB lift-out and Transmission Electron Mi-
croscopy at The Nanoscale and Microscale Research Centre (NMRC), 
University of Nottingham, UK. The authors would like to thank Saul 
Vazquez Reina (University of Nottingham, UK), Lucia Leonat and Cris-
tina Besleaga (National Institute of Materials Physics, Romania) for the 
assistance provided with the ICP-MS, FE-SEM and AFM analyses, 
respectively. 
References 
[1] World Health Organization, Antimicrobial resistance. https://www.who.int/ne 
ws-room/fact-sheets/detail/antimicrobial-resistance, 2018. April 17, 2021. 
[2] B. Li, T.J. Webster, Bacteria antibiotic resistance: new challenges and 
opportunities for implant-associated orthopedic infections, J. Orthop. Res. 36 
(2018) 22–32, https://doi.org/10.1002/jor.23656. 
[3] A.C. Popa, H.R. Fernandes, M. Necsulescu, C. Luculescu, M. Cioangher, 
V. Dumitru, B.W. Stuart, D.M. Grant, J.M.F. Ferreira, G.E. Stan, Antibacterial 
efficiency of alkali-free bio-glasses incorporating ZnO and/or SrO as therapeutic 
agents, Ceram. Int. 45 (2019) 4368–4380, https://doi.org/10.1016/j. 
ceramint.2018.11.112. 
[4] 17th Annual Report, National joint Registry for England, Wales, Northern Ireland 
and the Isle of Man, 2020, pp. 1–312. https://reports.njrcentre.org. 
uk/Portals/0/PDFdownloads/NJR 17th Annual Report 2020.pdf. (Accessed 17 
April 2021). 
[5] S. Awasthi, S.K. Pandey, E. Arunan, C. Srivastava, A review on hydroxyapatite 
coatings for the biomedical applications: experimental and theoretical 
perspectives, J. Mater. Chem. B 9 (2021) 228–249, https://doi.org/10.1039/ 
D0TB02407D. 
[6] L. Drago, M. Toscano, M. Bottagisio, Recent evidence on bioactive glass 
antimicrobial and antibiofilm activity: a mini-review, Materials 11 (2018) 326, 
https://doi.org/10.3390/ma11020326. 
[7] R.A. Surmenev, M.A. Surmeneva, A.A. Ivanova, Significance of calcium 
phosphate coatings for the enhancement of new bone osteogenesis – a review, 
Acta Biomater. 10 (2014) 557–579, https://doi.org/10.1016/j. 
actbio.2013.10.036. 
[8] M. Epple, Review of potential health risks associated with nanoscopic calcium 
phosphate, Acta Biomater. 77 (2018) 1–14, https://doi.org/10.1016/j. 
actbio.2018.07.036. 
[9] D.S. Brauer, Phosphate glasses, in: J.R. Jones, A.G. Clare (Eds.), Bio-Glasses: an 
Introduction, John Wiley & Sons, Hoboken, 2012, pp. 45–64. 
[10] J. Henao, C. Poblano-Salas, M. Monsalve, J. Corona-Castuera, O. Barceinas- 
Sanchez, Bio-active glass coatings manufactured by thermal spray: a status report, 
J. Mater. Res. Technol 8 (2019) 4965–4984, https://doi.org/10.1016/j. 
jmrt.2019.07.011. 
[11] R. Sergi, D. Bellucci, V. Cannillo, A comprehensive review of bioactive glass 
coatings: state of the art, challenges and future perspectives, Coatings 10 (2020) 
757, https://doi.org/10.3390/coatings10080757. 
[12] R.D. Bloebaum, D. Beeks, L.D. Dorr, C.G. Savory, J.A. DuPont, A.A. Hofmann, 
Complications with hydroxyapatite particulate separation in total hip 
arthroplasty, Clin. Orthop. Relat. Res. 298 (1994) 19–26, https://doi.org/ 
10.1097/00003086-199401000-00005. 
[13] B. Li, X. Xia, M. Guo, Y. Jiang, Y. Li, Z. Zhang, S. Liu, H. Li, C. Liang, H. Wang, 
Biological and antibacterial properties of the micro-nanostructured 
hydroxyapatite/chitosan coating on titanium, Sci. Rep. 9 (2019) 14052, https:// 
doi.org/10.1038/s41598-019-49941-0. 
[14] B.W. Stuart, M. Gimeno-Fabra, J. Segal, I. Ahmed, D.M. Grant, Degradation and 
characterization of resorbable phosphate-based glass thin-film coatings applied 
by radio-frequency magnetron sputtering, ACS Appl. Mater. Interfaces 7 (2015) 
27362–27372, https://doi.org/10.1021/acsami.5b08957. 
[15] J. Ballarre, T. Aydemir, L. Liverani, J.A. Roether, W.H. Goldmann, A. 
R. Boccaccini, Versatile bioactive and antibacterial coating system based on silica, 
gentamicin, and chitosan: improving early stage performance of titanium 
implants, Surf. Coating. Technol. 381 (2020), 125138, https://doi.org/10.1016/j. 
surfcoat.2019.125138. 
[16] A. Kulkarni Aranya, S. Pushalkar, M. Zhao, R.Z. LeGeros, Y. Zhang, D. Saxena, 
Antibacterial and bioactive coatings on titanium implant surfaces, J. Biomed. 
Mater. Res. 105 (2017) 2218–2227, https://doi.org/10.1002/jbm.a.36081. 
[17] E.L. Cyphert, H.A. von Recum, Emerging technologies for long-term antimicrobial 
device coatings: advantages and limitations, Exp. Biol. Med. 242 (2017) 788–798, 
https://doi.org/10.1177/1535370216688572. 
[18] T. Tite, A.C. Popa, L.M. Balescu, I.M. Bogdan, I. Pasuk, J.M.F. Ferreira, G.E. Stan, 
Cationic substitutions in hydroxyapatite: current status of the derived 
biofunctional effects and their in vitro interrogation methods, Materials 11 
(2018) 2081, https://doi.org/10.3390/ma11112081. 
[19] L. Ramos Rivera, A. Cochis, S. Bisera, E. Canciani, S. Ferraris, L. Rimondini, A. 
R. Boccaccini, Antibacterial, pro-angiogenic and pro-osteointegrative zein- 
bioactive glass/copper based coatings for implantable stainless steel aimed at 
bone healing, Bioactive Mater 6 (2021) 1479–1490, https://doi.org/10.1016/j. 
bioactmat.2020.11.001. 
[20] L.D. Soule, N. Pajares Chomorro, K. Chuong, N. Mellott, N. Hammer, K. 
D. Hankenson, X. Chatzistavrou, Sol–Gel-derived bioactive and antibacterial 
multi-component thin films by the spin-coating technique, ACS Biomater. Sci. 
Eng. 6 (2020) 5549–5562, https://doi.org/10.1021/acsbiomaterials.0c01140. 
[21] A.A. Ivanova, M.A. Surmeneva, A.I. Tyurin, T.S. Pirozhkova, I.A. Shuvarin, 
O. Prymak, M. Epple, M.V. Chaikina, R.A. Surmenev, Fabrication and physico- 
mechanical properties of thin magnetron sputter deposited silver-containing 
hydroxyapatite films, Appl. Surf. Sci. 360 (2016) 929–935, https://doi.org/ 
10.1016/j.apsusc.2015.11.087. Part B. 
[22] G. Popescu-Pelin, C. Ristoscu, L. Duta, G.E. Stan, I. Pasuk, T. Tite, M.S. Stan, 
C. Bleotu, M. Popa, M.C. Chifiriuc, F.N. Oktar, A. Nicarel, I.N. Mihailescu, 
Antimicrobial and cytocompatible bovine hydroxyapatite-alumina-zeolite 
composite coatings synthesized by pulsed laser deposition from low-cost 
sustainable natural resources, ACS Sustain. Chem. Eng. 8 (2020) 4026–4036, 
https://doi.org/10.1021/acssuschemeng.9b05031. 
[23] M.T. Islam, R.M. Felfel, E.A. Abou Neel, D.M. Grant, I. Ahmed, K.M.Z. Hossain, 
Bioactive calcium phosphate–based glasses and ceramics and their biomedical 
applications: a review, J. Tissue Eng. 8 (2017), https://doi.org/10.1177/ 
2041731417719170, 2041731417719170. 
[24] N.J. Lakhkar, I.H. Lee, H.W. Kim, V. Salih, I.B. Wall, J.C. Knowles, Bone 
formation controlled by biologically relevant inorganic ions: role and controlled 
delivery from phosphate-based glasses, Adv. Drug Deliv. Rev. 65 (2013) 405–420, 
https://doi.org/10.1016/j.addr.2012.05.015. 
[25] M. Al Qaysi, A. Petrie, R. Shah, J.C. Knowles, Degradation of zinc containing 
phosphate-based glass as a material for orthopedic tissue engineering, J. Mater. 
Sci. Mater. Med. 27 (2016) 157, https://doi.org/10.1007/s10856-016-5770-x. 
B.W. Stuart et al.                                                                                                                                                                                                                               
Bioactive Materials xxx (xxxx) xxx
15
[26] B.W. Stuart, M. Gimeno-Fabra, J. Segal, I. Ahmed, D.M. Grant, Mechanical, 
structural and dissolution properties of heat treated thin-film phosphate based 
glasses, Appl. Surf. Sci. 416 (2017) 605–617, https://doi.org/10.1016/j. 
apsusc.2017.04.110. 
[27] E. Mohseni, E. Zalnezhad, A.R. Bushroa, Comparative investigation on the 
adhesion of hydroxyapatite coating on Ti-6Al-4V implant: a review paper, Int. J. 
Adhesion Adhes. 48 (2014) 238–257, https://doi.org/10.1016/j. 
ijadhadh.2013.09.030. 
[28] A. Frei, Metal complexes, an untapped source of antibiotic potential? Antibiotics 
9 (2020) 90, https://doi.org/10.3390/antibiotics9020090. 
[29] J.R. Morones-Ramirez, J.A. Winkler, C.S. Spina, J.J. Collins, Silver enhances 
antibiotic activity against gram-negative bacteria, Sci. Transl. Med. 5 (2013), 
190ra81, https://doi.org/10.1126/scitranslmed.3006276. 
[30] A.B.G. Lansdown, Silver in health care: antimicrobial effects and safety in use, 
Curr. Probl. Dermatol. 33 (2006) 17–34, https://doi.org/10.1159/000093928. 
[31] N. Hadrup, A.K. Sharma, K. Loeschner, Toxicity of silver ions, metallic silver, and 
silver nanoparticle materials after in vivo dermal and mucosal surface exposure: a 
review, Regul. Toxicol. Pharmacol. 98 (2018) 257–267, https://doi.org/10.1016/ 
j.yrtph.2018.08.007. 
[32] S. Crunkhorn, Gallium fights infection in phase I trial, Nat. Rev. Drug Discov. 17 
(2018) 786, https://doi.org/10.1038/nrd.2018.186. 
[33] S. Hijazi, D. Visaggio, M. Pirolo, E. Frangipani, L. Bernstein, P. Visca, 
Antimicrobial activity of gallium compounds on ESKAPE pathogens, Front. Cell. 
Infect. Microbiol. 8 (2018) 316, https://doi.org/10.3389/fcimb.2018.00316. 
[34] C.H. Goss, Y. Kaneko, L. Khuu, G.D. Anderson, S. Ravishankar, M.L. Aitken, 
N. Lechtzin, G. Zhou, D.M. Czyz, K. McLean, O. Olakanmi, H.A. Shuman, 
M. Teresi, E. Wilhelm, E. Caldwell, S.J. Salipante, D.B. Hornick, R.J. Siehnel, 
L. Becker, B.E. Britigan, P.K. Singh, Gallium disrupts bacterial iron metabolism 
and has therapeutic effects in mice and humans with lung infections, Sci. Transl. 
Med. 10 (2018), eaat7520, https://doi.org/10.1126/scitranslmed.aat7520. 
[35] L.C.S. Antunes, F. Imperi, F. Minandri, P. Visca, In vitro and in vivo antimicrobial 
activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii, 
Antimicrob. Agents Chemother. 56 (2012) 5961–5970, https://doi.org/10.1128/ 
AAC.01519-12. 
[36] F. Minandri, C. Bonchi, E. Frangipani, F. Imperi, P. Visca, Promises and failures of 
gallium as an antibacterial agent, Future Microbiol. 9 (2014) 379–397, https:// 
doi.org/10.2217/fmb.14.3. 
[37] I. Ahmed, E.A. Abou Neel, S.P. Valappil, S.N. Nazhat, D.M. Pickup, D. Carta, D. 
L. Carroll, R.J. Newport, M.E. Smith, J.C. Knowles, The structure and properties 
of silver-doped phosphate-based glasses, J. Mater. Sci. 42 (2007) 9827–9835, 
https://doi.org/10.1007/s10853-007-2008-9. 
[38] S. Lee, T. Nakano, T. Kasuga, Structure, dissolution behavior, cytocompatibility, 
and antibacterial activity of silver-containing calcium phosphate invert glasses, 
J. Biomed. Mater. Res. 105 (2017) 3127–3135, https://doi.org/10.1002/jbm. 
a.36173. 
[39] B.A. Kyffin, F. Foroutan, S.E. Taylor, D. Carta, F.N.S. Raja, R.A. Martin, D. 
M. Pickup, Antibacterial silver-doped phosphate-based glasses prepared by 
coacervation, J. Mater. Chem. B. 7 (2019) 7744–7755, https://doi.org/10.1039/ 
c9tb02195g. 
[40] S.P. Valappil, D. Ready, E.A. Abou Neel, D.M. Pickup, L.A. O’Dell, 
W. Chrzanowski, J. Pratten, R.J. Newport, M.E. Smith, M. Wilson, J.C. Knowles, 
Controlled delivery of antimicrobial gallium ions from phosphate-based glasses, 
Acta Biomater. 5 (2009) 1198–1210, https://doi.org/10.1016/j. 
actbio.2008.09.019. 
[41] A. Łapa, M. Cresswell, I. Campbell, P. Jackson, W.H. Goldmann, R. Detsch, A. 
R. Boccaccini, Gallium- and Cerium-doped phosphate glasses with antibacterial 
properties for medical applications, Adv. Eng. Mater. 22 (2020), 1901577, 
https://doi.org/10.1002/adem.201901577. 
[42] K. Wasa, I. Kanno, H. Kotera, Handbook of Sputter Deposition Technology: 
Fundamentals and Applications for Functional Thin Films, in: Nano-Materials and 
MEMS, second ed., Elsevier, 2012, pp. 1–644, https://doi.org/10.1016/C2010-0- 
67037-4. 
[43] C. Besleaga, V. Dumitru, L.M. Trinca, A.C. Popa, C.C. Negrila, Ł. Kołodziejczyk, C. 
R. Luculescu, G.C. Ionescu, R.G. Ripeanu, A. Vladescu, G.E. Stan, Mechanical, 
corrosion and biological properties of room-temperature sputtered aluminum 
nitride films with dissimilar nanostructure, Nanomaterials 7 (2017) 394, https:// 
doi.org/10.3390/nano7110394. 
[44] G.E. Stan, A.C. Popescu, I.N. Mihailescu, D.A. Marcov, R.C. Mustata, L.E. Sima, S. 
M. Petrescu, A. Ianculescu, R. Trusca, C.O. Morosanu, On the bioactivity of 
adherent bioglass thin films synthesized by magnetron sputtering techniques, 
Thin Solid Films 518 (2010) 5955–5964, https://doi.org/10.1016/j. 
tsf.2010.05.104. 
[45] A.C. Popa, V.M.F. Marques, G.E. Stan, M.A. Husanu, A.C. Galca, C. Ghica, D. 
U. Tulyaganov, A.F. Lemos, J.M.F. Ferreira, Nanomechanical characterization of 
bioglass films synthesized by magnetron sputtering, Thin Solid Films 553 (2014) 
166–172, https://doi.org/10.1016/j.tsf.2013.10.104. 
[46] B.W. Stuart, J.J. Titman, M. Gimeno-Fabra, I. Ahmed, D.M. Grant, Insights into 
structural characterisation and thermal properties of compositionally equivalent 
vapour-condensed and melt-quenched glasses, Mater. Des. 111 (2016) 174–184, 
https://doi.org/10.1016/j.matdes.2016.08.063. 
[47] T. Tite, A.C. Popa, I.M. Chirica, B.W. Stuart, A.C. Galca, L.M. Balescu, G. Popescu- 
Pelin, D.M. Grant, J.M.F. Ferreira, G.E. Stan, Phosphate bioglass thin-films: cross- 
area uniformity, structure and biological performance tailored by the simple 
modification of magnetron sputtering gas pressure, Appl. Surf. Sci. 541 (2021), 
148640, https://doi.org/10.1016/j.apsusc.2020.148640. 
[48] B. Stuart, M. Gimeno-Fabra, J. Segal, I. Ahmed, D.M. Grant, Preferential 
sputtering in phosphate glass systems for the processing of bioactive coatings, 
Thin Solid Films 589 (2015) 534–542, https://doi.org/10.1016/j. 
tsf.2015.05.072. 
[49] P.S. Sato, T. Watanabe, H. Maeda, A. Obata, T. Kasuga, Preparation of an 
antibacterial amorphous thin film by radiofrequency magnetron sputtering using 
a 65ZnO–30P2O5–5Nb2O5 glass, J. Non-Cryst. Solids 528 (2020), 119724, 
https://doi.org/10.1016/j.jnoncrysol.2019.119724. 
[50] B.W. Stuart, C.A. Grant, G.E. Stan, A.C. Popa, J.J. Titman, D.M. Grant, Gallium 
incorporation into phosphate based glasses: bulk and thin film properties, 
J. Mech. Behav. Biomed. Mater. 82 (2018) 371–382, https://doi.org/10.1016/j. 
jmbbm.2018.03.041. 
[51] A.B.G. Lansdown, A pharmacological and toxicological profile of silver as an 
antimicrobial agent in medical devices, Adv. Pharmacol. Sci. (2010), 910686, 
https://doi.org/10.1155/2010/910686, 2010. 
[52] F. Sambale, S. Wagner, F. Stahl, R.R. Khaydarov, T. Scheper, D. Bahnemann, 
Investigations of the toxic effect of silver nanoparticles on mammalian cell lines, 
J. Nanomater. (2015), 136765, https://doi.org/10.1155/2015/136765, 2015. 
[53] https://www.who.int/water_sanitation_health/publications/silver-02032018. 
pdf. (Accessed 17 April 2021). 
[54] S.B. Goodman, The effects of micromotion and particulate materials on tissue 
differentiation: bone chamber studies in rabbits, Acta Orthop. Scand. 65 (1994) 
1–43, https://doi.org/10.3109/17453679409155227. 
[55] G.E. Stan, T. Tite, A.-C. Popa, I.M. Chirica, C.C. Negrila, C. Besleaga, I. Zgura, A. 
C. Sergentu, G. Popescu-Pelin, D. Cristea, L.E. Ionescu, M. Necsulescu, H. 
R. Fernandes, J.M.F. Ferreira, The beneficial mechanical and biological outcomes 
of thin Copper-Gallium doped silica-rich bio-active glass implant-type coatings, 
Coatings 10 (2020) 1119, https://doi.org/10.3390/coatings10111119. 
[56] D.K. Owens, R.C. Wendt, Estimation of the surface free energy of polymers, 
J. Appl. Polym. Sci. 13 (1969) 1741–1747, https://doi.org/10.1002/ 
app.1969.070130815. 
[57] International Organization for Standardization, ISO 10993-5:2009 - biological 
evaluation of medical devices. Part 5: tests for in vitro cytotoxicity, Geneva, 
Switzerland. https://www.iso.org/standard/36406.html, 2009. 
[58] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter, Molecular Biology 
of the Cell, fourth ed., Garland Science, New York, 2002. 
[59] International Organization for Standardization, ISO 22196:2011 - measurement 
of antibacterial activity on plastics and other non-porous surfaces, Geneva, 
Switzerland. https://www.iso.org/standard/54431.html, 2011. 
[60] C.E. Heim, D. Vidlak, T.D. Scherr, C.W. Hartman, K.L. Garvin, T. Kielian, IL-12 
promotes myeloid-derived suppressor cell recruitment and bacterial persistence 
during Staphylococcus aureus orthopedic implant infection, J. Immunol. 194 
(2015) 3861–3872, https://doi.org/10.4049/jimmunol.1402689. 
[61] C.R. Arciola, D. Campoccia, L. Montanaro, Implant infections: adhesion, biofilm 
formation and immune evasion, Nat. Rev. Microbiol. 16 (2018) 397–409, https:// 
doi.org/10.1038/s41579-018-0019-y. 
[62] L. Montanaro, P. Speziale, D. Campoccia, S. Ravaioli, I. Cangini, G. Pietrocola, 
S. Giannini, C.R. Arciola, Scenery of Staphylococcus implant infections in 
orthopedics, Future Microbiol. 6 (2011) 1329–1349, https://doi.org/10.2217/ 
fmb.11.117. 
[63] A.D. Pye, D.E.A. Lockhart, M.P. Dawson, C.A. Murray, A.J. Smith, A review of 
dental implants and infection, J. Hosp. Infect. 72 (2009) 104–110, https://doi. 
org/10.1016/j.jhin.2009.02.010. 
[64] W.F. Oliveira, P.M.S. Silva, R.C.S. Silva, G.M.M. Silva, G. Machado, L.C.B. 
B. Coelho, M.T.S. Correia, Staphylococcus aureus and Staphylococcus epidermidis 
infections on implants, J. Hosp. Infect. 98 (2018) 111–117, https://doi.org/ 
10.1016/j.jhin.2017.11.008. 
[65] Z. Khatoon, C.D. McTiernan, E.J. Suuronen, T.-F. Mah, E.I. Alarcon, Bacterial 
biofilm formation on implantable devices and approaches to its treatment and 
prevention, Heliyon 4 (2018), e01067, https://doi.org/10.1016/j.heliyon.2018. 
e01067. 
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